IFF Releases New Findings for Conditioning Biopolymer Aurist AGC

A new study demonstrates the International Flavor and Fragrances’ Aurist AGC—a water-soluble, readily biodegradable cationic biopolymer – is effective in improving the performance of body wash products. 

 

Initially offered as a hair conditioning polymer – Aurist AGC also improves skin roughness in skin cleansing and body wash applications. These new insights underscore the ability of IFF’s proprietary Designed Enzymatic Biopolymer (DEB) technology to deliver scalable, performance-oriented, sustainable personal care solutions. 

 

“We are dedicated to assessing the untapped potential of our ingredients, adapting to evolving market dynamics and empowering our customers to deliver innovative benefits across many applications,” said Johan Jansén-Storbacka, director, personal care, IFF. “With this clinical data, we can extend Aurist AGC’s transformative impact further into the skincare space.”

The clinical study by expert panelists aimed to determine the sensory benefits Aurist AGC brings to skin cleansing formulations. The results showed that the panelists experienced a significant reduction in skin roughness and a smooth and silky residual feel after using cleansers containing Aurist AGC.

 

The study also evaluated rinsability. In recent Mintel reports, speed has appeared as a consistently cited claim for new shower-product launches from 2020 onwards, and 66% of surveyed consumers want to reduce their time spent in the shower. During the study, the panelists observed a substantially reduced rinsing time when using formulations containing Aurist AGC.

 

Launched in March this year, Aurist AGC is part of IFF’s new Aurist functional line. This collection comprises natural and nature-inspired solutions designed to deliver benefits across leave-in or rinse-off products for both the skincare and haircare segments. This novel, readily biodegradable conditioning biopolymer was awarded the gold prize for Best Functional Ingredient at the 2023 in-Cosmetics Global Innovation Zone. 

 

“The latest findings demonstrate the value the DEB technology can bring to the industry,” said Wayne Ashton, vice president, home & personal care, IFF. “We are committed to continuing our investment in biotechnology and Aurist AGC, and we believe the DEB platform can deliver outstanding results that meet our customers’ expectations for enhanced sustainability.”